BioSpace May 26, 2020 Abivax announces German regulatory approval of ABX464 Covid-19 Phase 2b/3 COVID-19 clinical trial
Pharmabiz.com May 26, 2020 Abivax gets German regulatory approval to begin phase 2b/3 study of ABX464 to treat COVID-19
Bourse Direct 25 mai 2020 Abivax : autorisation des autorités réglementaires allemandes pour l’essai de phase 2B/3 d’ABX464 dans le Covid-19
